BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10471641)

  • 1. Quantitative reverse transcription-PCR assay with an internal standard for the detection of prostate-specific antigen mRNA.
    Ylikoski A; Sjöroos M; Lundwall A; Karp M; Lövgren T; Lilja H; Iitiä A
    Clin Chem; 1999 Sep; 45(9):1397-407. PubMed ID: 10471641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-label detection of amplified products in quantitative RT-PCR assay using lanthanide-labeled probes.
    Ylikoski A; Karp M; Lilja H; Lövgren T
    Biotechniques; 2001 Apr; 30(4):832-6, 838, 840 passim. PubMed ID: 11314266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-Time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the taqman detection system.
    Gelmini S; Tricarico C; Vona G; Livi L; Melina AD; Serni S; Cellai E; Magrini S; Villari D; Carini M; Serio M; Forti G; Pazzagli M; Orlando C
    Clin Chem Lab Med; 2001 May; 39(5):385-91. PubMed ID: 11434386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of prostate specific antigen mRNA in peripheral blood by reverse transcriptase polymerase chain reaction and a simple chemiluminometric hybridization assay in a high-throughput format.
    Emmanouilidou E; Ioannou PC; Christopoulos TK; Polizois K
    Anal Biochem; 2003 Feb; 313(1):97-105. PubMed ID: 12576064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative PSA RT-PCR for preoperative staging of prostate cancer.
    Kurek R; Ylikoski A; Renneberg H; Konrad L; Aumüller G; Roddiger SJ; Zamboglou N; Tunn UW; Lilja H
    Prostate; 2003 Sep; 56(4):263-9. PubMed ID: 12858354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using "Light-Cycler"-based quantitative real-time polymerase chain reaction.
    Straub B; Müller M; Krause H; Schrader M; Goessl C; Heicappell R; Miller K
    Urology; 2001 Nov; 58(5):815-20. PubMed ID: 11711374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.
    Ishikawa T; Kashiwagi H; Iwakami Y; Hirai M; Kawamura T; Aiyoshi Y; Yashiro T; Ami Y; Uchida K; Miwa M
    Jpn J Clin Oncol; 1998 Dec; 28(12):723-8. PubMed ID: 9879288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications.
    Millon R; Jacqmin D; Muller D; Guillot J; Eber M; Abecassis J
    Eur Urol; 1999 Oct; 36(4):278-85. PubMed ID: 10473985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative real-time rt-PCR for detection of circulating prostate-specific antigen mRNA using sequence-specific oligonucleotide hybridization probes in prostate cancer patients.
    Straub B; Müller M; Krause H; Schrader M; Miller K
    Oncology; 2003; 65 Suppl 1():12-7. PubMed ID: 12949428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of prostate specific antigen mRNA levels in circulation after prostatic surgery and endocrine treatment by quantitative reverse transcription-polymerase chain reaction.
    Lintula S; Vesalainen S; Rannikko A; Zhang WM; Finne P; Stenman J; Stenman UH
    Scand J Clin Lab Invest; 2004 Apr; 64(2):93-100. PubMed ID: 15115245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Numeric definition of the clinical performance of the nested reverse transcription-PCR for detection of hematogenous epithelial cells and correction for specific mRNA of non-target cell origin as evaluated for prostate cancer cells.
    Schamhart D; Swinnen J; Kurth KH; Westerhof A; Kusters R; Borchers H; Sternberg C
    Clin Chem; 2003 Sep; 49(9):1458-66. PubMed ID: 12928226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
    Gomella LG; Raj GV; Moreno JG
    J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased analytical sensitivity of RT-PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in blood.
    Henke W; Jung M; Jung K; Lein M; Schlechte H; Berndt C; Rudolph B; Schnorr D; Loening SA
    Int J Cancer; 1997 Jan; 70(1):52-6. PubMed ID: 8985090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patients.
    Ylikoski A; Karp M; Pettersson K; Lilja H; Lövgren T
    J Mol Diagn; 2001 Aug; 3(3):111-22. PubMed ID: 11486050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of circulating tumor cells in men with localized prostate cancer.
    Seiden MV; Kantoff PW; Krithivas K; Propert K; Bryant M; Haltom E; Gaynes L; Kaplan I; Bubley G; DeWolf W
    J Clin Oncol; 1994 Dec; 12(12):2634-9. PubMed ID: 7527455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative real-time reverse transcription: polymerase chain reaction of prostate-specific antigen (PSA) for detection of circulating prostatic cells in patients with clinically localized prostate cancer.
    Llanes L; Ferruelo A; Luján M; Pascual C; García-Mediero JM; Berenguer A
    Prostate Cancer Prostatic Dis; 2005; 8(3):248-52. PubMed ID: 15897916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.
    Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H
    Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous quantification of prostate-specific antigen and human glandular kallikrein 2 mRNA in blood samples from patients with prostate cancer and benign disease.
    Ylikoski A; Pettersson K; Nurmi J; Irjala K; Karp M; Lilja H; Lövgren T; Nurmi M
    Clin Chem; 2002 Aug; 48(8):1265-71. PubMed ID: 12142383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages.
    Corey E; Arfman EW; Oswin MM; Melchior SW; Tindall DJ; Young CY; Ellis WJ; Vessella RL
    Urology; 1997 Aug; 50(2):184-8. PubMed ID: 9255285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction.
    Ghossein RA; Osman I; Bhattacharya S; Ferrara J; Fazzari M; Cordon-Cardo C; Scher HI
    Diagn Mol Pathol; 1999 Jun; 8(2):59-65. PubMed ID: 10475379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.